Buscar
Mostrando ítems 21-30 de 94
Serum Potassium Dynamics During Acute Heart Failure Hospitalization
(Springer, 2020-10-17)
[Abstract]
Background.
Available information about prognostic implications of potassium levels alteration in the setting of acute heart failure (AHF) is scarce.
Objectives.
We aim to describe the prevalence of ...
Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use
(Wolters Kluwer, 2020-07)
[Abstract]
Levosimendan was first approved for clinical use in 2000, when authorization was granted by Swedish regulatory authorities for the hemodynamic stabilization of patients with acutely decompensated chronic heart ...
Spanish Heart Transplant Registry: 31th Official Report of the Heart Failure Association of the Spanish Society of Cardiology
(Elsevier, 2020-08-14)
[Abstract]
Introduction and objectives.
The present report describes the clinical characteristics and outcomes of heart transplants in Spain and updates the data to 2019.
Methods.
We describe the clinical characteristics ...
Circulating miR-181a-5p as a New Biomarker for Acute Cellular Rejection in Heart Transplantation
(Elsevier, 2020-06-07)
[Abstract] Background: Acute cellular rejection (ACR) is a major complication in heart transplantation (HTx). Endomyocardial biopsy is the reference method for early detection of ACR, but a new non-invasive approach is ...
Prognostic value of discharge heart rate in acute heart failure patients: more relevant in atrial fibrillation?
(Elsevier, 2020-02)
[Abstract]
Aims.
The prognostic impact of heart rate (HR) in acute heart failure (AHF) patients is not well known especially in atrial fibrillation (AF) patients. The aim of the study was to evaluate the impact of admission ...
Persistent Pulmonary Hypertension in Corrected Valvular Heart Disease: Hemodynamic Insights and Long‐Term Survival
(Willey, 2021-01-19)
[Abstract]
Background. The determinants and consequences of pulmonary hypertension after successfully corrected valvular heart disease remain poorly understood. We aim to clarify the hemodynamic bases and risk factors for ...
Is degree of chronic illness management in heart transplant centers associated with better patient survival?: findings from the intercontinental BRIGHT study
(SAGE, 2021-09-22)
[Abstract] Purpose: To explore the association between the degree of Chronic illness management and survival rates at 1-, 3-, 5-years post heart transplantation.
Methods: Exploratory secondary analysis of a cross-sectional, ...
Syncope in patients with transthyretin amyloid cardiomyopathy: clinical features and outcomes
(Taylor & Francis, 2022-03-23)
[Abstract] Background: We aimed to describe the clinical characteristics, underlying causes and outcomes of syncope in patients with transthyretin amyloid cardiomyopathy (ATTR-CM).
Methods: The clinical profile and ...
Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure
(Massachusetts Medical Society, 2020-11-13)
[Abstract]
BACKGROUND.
The selective cardiac myosin activator omecamtiv mecarbil has been shown to improve cardiac function in patients with heart failure with a reduced ejection fraction.
Its effect on cardiovascular ...
Impact of Donor-Recipient Age on Cardiac Transplant Survival. Subanalysis of the Spanish Heart Transplant Registry
(Elsevier, 2020-06-26)
[Abstract]
Introduction and objectives.
The age of heart transplant recipients and donors is progressively increasing. It is likely that not all donor-recipient age combinations have the same impact on mortality. The ...